e-learning
resources
Berlin 2008
Monday, 06.10.2008
Improving asthma and anti-allergic therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduction of treatment time for nebulized treatments using a new adaptive aerosol delivery mode
I. Prince, A. Black, C. Smart, K. Nikander, T. Dyche, J. Denyer (Chichester, United Kingdom; Parsippany, NJ, United States Of America)
Source:
Annual Congress 2008 - Improving asthma and anti-allergic therapy
Session:
Improving asthma and anti-allergic therapy
Session type:
Thematic Poster Session
Number:
2020
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Prince, A. Black, C. Smart, K. Nikander, T. Dyche, J. Denyer (Chichester, United Kingdom; Parsippany, NJ, United States Of America). Reduction of treatment time for nebulized treatments using a new adaptive aerosol delivery mode. Eur Respir J 2008; 32: Suppl. 52, 2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Long inhalation time is associated with short treatment time when using the I-neb AAD system in target inhalation mode
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007
Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Reduction in nebulisation time of aqueous drug solutions by the eFlow rapid in comparison to a jet nebuliser to improve patient convenience and compliance
Source: Eur Respir J 2005; 26: Suppl. 49, 338s
Year: 2005
Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination
Year: 2007
Influence of nebulizer type, position and bias flow on aerosol drug delivery to a pediatric model of mechanical ventilation
Source: Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Year: 2008
Reduction of nebulization time can be achieved with a new jet nebulizer design
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006
Comparison of aerosol delivery from two inhaler technique-guidance devices.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Characterization of the performance of a new portable jet nebulizer system for the delivery of budesonide suspension for nebulization
Source: Annual Congress 2008 - Wheezing in preschool children
Year: 2008
Combination of electronically controlled breathing pattern and improved nebulizer technology for inhaled corticosteroid therapy of severe asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Precise dosing of five drugs commonly used by patients with cystic fibrosis using an adaptive aerosol delivery system
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011
Effect of different connections on aerosol delivery during non-invasive mechanical ventilation.
Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Year: 2020
Use of a telemedicine application to examine patient logging system data from a 3-month use of an adaptive aerosol delivery system by patients with COPD
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008
In vitro evaluation of aerosolized delivery of various medications during mechanical ventilation
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017
What the pulmonary specialist should know about the new inhalation therapies
Source: Eur Respir J 2011; 37: 1308-1417
Year: 2011
Can the use of adaptive aerosol delivery technology increase the quality of life for patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007
Comparison of response to aerosol drug delivery with mesh and jet nebulizers during non-invasive ventilation (NIV) in acute exacerbation of COPD.
Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept